Author: ThomasS111
Creative Diagnostics Launches Plaque Reduction Assay Services to Advance Antiviral Research
Creative Diagnostics is proud to announce Plaque Reduction Assay services to support antiviral research. As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is proud to announce the launch of its comprehensive suite of Plaque Reduction Assay services to support antiviral research. These new solutions offer researchers a powerful and well-established method for evaluating the efficacy of antiviral compounds. Normal cells can absorb reactive dyes during metabolism, but when the cells are infected with a virus, they lose their ability to absorb the dye, resulting in the formation of colorless plaques. When a virus is neutralized by…
Creative Diagnostics Announces the Launch of Norovirus VLP Antigens to Support Vaccine Research
Creative Diagnostics announces its new line of Norovirus VLP Antigens for in vitro diagnostics and vaccine research. Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is pleased to announce the availability of its new line of Norovirus VLP Antigens to accelerate in vitro diagnostics and vaccine research. These new antigens have been validated to a high level of confidence using electron microscopy. Norovirus is a non-enveloped, positive-sense, single-stranded RNA virus of the family Caliciviridae and is the leading cause of non-bacterial acute gastroenteritis worldwide. The infection is characterized by non-bloody diarrhea, vomiting and abdominal pain. The stability…